News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Klee Justin B.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/20/2023 |
4
| Klee Justin B. (Co-CEO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 96,555 shares
@ $31.8405, valued at
$3.1M
Sold 3,445 shares
@ $32.4751, valued at
$111.9k
Granted 50,000 shares
@ $0
Granted 225,000 options to buy
@ $32.08, valued at
$7.2M
|
|
| 03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 01/10/2023 |
4
| Klee Justin B. (Co-CEO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 4,122 shares
@ $36.0789, valued at
$148.7k
Sold 1,846 shares
@ $36.7888, valued at
$67.9k
|
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2022 |
4
| Klee Justin B. (Co-CEO) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Converted 4,870 shares
@ $0
Granted 75,000 shares
@ $0
Converted 4,870 preferred shares
@ $0
Granted 337,500 options to buy
@ $19, valued at
$6.4M
|
|
| 01/06/2022 |
3
| Klee Justin B. (Co-CEO) has filed a Form 3 on Amylyx Pharmaceuticals, Inc. |
|
|